Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Annales De Medecine Interne|February 18, 1999
[Acute myelocytic leukemia in immunodeficiency virus infection]M Pulik, F Lionnet, P Genet, et al.AIDS Patient Care and Stds|May 22, 2001
Acute myeloid leukemias, multiple myelomas, and chronic leukemias in the setting of HIV infectionM Pulik, P Genet, L Jary, et al.The Journal of Rheumatology|February 7, 1998
Remission of nonerosive polyarthritis associated with Sjögren's syndrome after autologous hematopoietic stem cell transplantation for lymphomaK Jondeau, C Job-Deslandre, D Bouscary, et al.Bone Marrow Transplantation|August 31, 2002
Acute myocardial ischemia after high-dose therapy with BEAM regimenP Genet, M Pulik, B Gallet, et al.Leukemia|November 1, 1996
Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromesK Jondeau, D Bouscary, F Viguié, et al.La Revue De Medecine Interne|February 3, 2021
[Pseudohyperkalemia and thrombocytosis]E Le Goff, K Jondeau, M-D Venon, et al.Leukemia|June 1, 1997
Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromesD Bouscary, J De Vos, M Guesnu, et al.Leukemia & Lymphoma|May 26, 1999
Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia veraD Bouscary, K Jondeau, F Viguié, et al.Cell Death & Disease|October 10, 2014
Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727C Capron, K Jondeau, L Casetti, et al.Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.Pageof 1